Read + Share
Amedeo Smart
Independent Medical Education
Xiang H, She Z, Wang L, Peng Y, et al. Comparison of Atezolizumab plus Aevacizumab and Atezolizumab plus Aabozantinib for advanced hepatocellular carcinoma: A cost-effectiveness analysis. PLoS One 2025;20:e0337606.PMID: 41335584
Email
LinkedIn
Privacy Policy